What is the issue size of Maitreya Medicare IPO?

The issue size of the Maitreya Medicare IPO is Rs 14.89 cr

What is 'pre-apply' for Maitreya Medicare IPO?

Pre-apply will alow you to apply for the Maitreya Medicare IPO 2 days before the subscription period starts.

If I pre-apply for Maitreya Medicare IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Maitreya Medicare IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Maitreya Medicare IPO order is placed?

We will notify you when your Maitreya Medicare IPO order is placed with the exchange.

What are the open and close dates of the for Maitreya Medicare IPO?

Maitreya Medicare IPO will be open between 27 Oct - 1 Nov, 2023.

What is the lot size and minimum order quantity of the Maitreya Medicare IPO?

Maitreya Medicare Limited IPO lot size is 1600 shares.

What are the allotment dates for the Maitreya Medicare IPO?

Maitreya Medicare IPO allotment date is 6 Nov, 2023. For Maitreya Medicare IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Maitreya Medicare IPO?

Maitreya Medicare IPO registrar is Link Intime India Private Ltd. You can check Maitreya Medicare IPO allotment status on the website of the registrar.

Where is the Maitreya Medicare IPO getting listed?

The shares are proposed to be listed on NSE SME.

Maitreya Medicare IPO

Maitreya Medicare Limited

₹1,24,800 /1600 sharesMinimum Investment

Maitreya Medicare IPO Listing DetailsListed OnIssue PriceListing PriceListing Gains
NSE₹82.00₹163.00₹81.00 (98.78%)
Maitreya Medicare IPO DetailsBidding DatesMin. InvestmentLot SizePrice Range
27 Oct ‘23 - 1 Nov ‘23₹1,24,8001,600₹78 - ₹82
Issue SizeIPO Doc
14.89CrRHP PDF
About Maitreya MedicareMaitreya Medicare Limited is a 125-bed multi-specialty hospital established in 2019 and located in Surat, Gujarat. Their core mission is to deliver comprehensive healthcare services covering primary, secondary, and tertiary care. They offer an extensive array of medical services across 18 different specialties and super specialties, which include cardiology, urology, oncology, laparoscopic surgery, neurology, neurosurgery, spine surgery, nephrology (including dialysis), gastroenterology, gastrointestinal surgery, cardiothoracic surgery, orthopedic surgery (including joint replacements and arthroscopic surgeries), gynecology & high-risk obstetrics, and critical care medicine.
As a full-service hospital, Maitreya Medicare operates independently, providing end-to-end healthcare solutions encompassing diagnostics, surgery, and rehabilitation.;
Parent Organisation
Maitreya Medicare Limited
Founded
2019
Managing Director
Dr. Narendra Singh Tanwar
Strengths & Risks
Maitreya Medicare is equipped with its Cathlab and two advanced Super Specialty Operating Theatres, with Laminar Air Flow and HEPA Filters. Additionally, they offer a 20-bed Intensive Care Unit equipped with ECMO and CRRT, along with essential support services like Pathology and Radiology, including CT scans.
Over the years, Maitreya Medicare's hospital has seen growth, expanding from 67 beds in 2021 to 100 beds in 2022 and now reaching a capacity of 125 beds in 2023.
Maitreya Medicare's has earned the NABH certification for both Maitreya Medicare Limited and their upcoming subsidiary, Maitreya Hospital Pvt Ltd in Valsad, Gujarat, which will also adhere to NABH standards.
Maitreya Medicare is currently in the process of establishing a 125-bed multi-specialty hospital in Valsad, Gujarat. This facility in Valsad City will be staffed by full-time super-specialist doctors, particularly in cardiology, neurology, and nephrology, providing advanced tertiary care services.
Maitreya Medicare heavily relies on healthcare professionals, such as doctors, nurses, and consultants. The loss of these professionals or the inability to attract and retain them could harm the company's business and financial results.
Legal proceedings involving the company may negatively impact its business, financial condition, and results of operations.
The company hasn't accounted for interest provisions according to the MSMED Act, 2006. It has also made payments to MSME vendors beyond the contractual time limit specified in the Act.
Revenue from government-sponsored health schemes is crucial for the company. Any adverse changes in regulations or government policies related to these schemes could harm the company's business, financial results, and prospects.
Maitreya Medicare is yet to apply for approvals and licenses for its Valsad hospital. A delay in obtaining these approvals could impact the company's revenues, credibility, and future plans.
Maitreya Medicare's operations are concentrated in Surat, Gujarat, and are vulnerable to localized social unrest and natural calamities.
Maitreya Medicare's revenue heavily depends on specific medical specialties like cardiology, neurology, orthopedics, and general medicine. Any significant impact on these fields could significantly affect its financial condition and results.
Maitreya Medicare relies on a limited number of external suppliers for medicines and consumables. Delays or failures in product delivery may harm the company's business, profitability, and reputation.
Unsecured loans totaling Rs. 1.10 crores were outstanding as of March 31, 2023.
Maintaining sufficient bed occupancy rates is critical to generate adequate returns on capital expenditure. Failing to do so may harm operating efficiencies and profitability.
Maitreya Medicare derives a substantial portion of its revenue from tie-up arrangements with governmental organizations, insurance companies, third-party administrators, and corporations. Losing major customers could significantly impact the company's operations and profitability.
Maitreya Medicare has experienced negative cash flows in the past and may continue to do so in the future, which could affect its ability to operate and implement growth plans, impacting its financial condition.
Maitreya Medicare has contingent liabilities totaling Rs. 0.40 crores as of September 30, 2023, which may affect its financial condition and results of operations.
Financials
*All values are in Rs. Cr
No Graph Data To Display
Application detailsApply asPrice bandApply upto
Regular₹78 - 82₹2 Lakh
High Networth Individual₹78 - 82₹2 - 5 Lakh
For Maitreya Medicare IPO, eligible investors can apply as Regular.

Listed On	Issue Price	Listing Price	Listing Gains
NSE	₹82.00	₹163.00	₹81.00 (98.78%)

Bidding Dates	Min. Investment	Lot Size	Price Range
27 Oct ‘23 - 1 Nov ‘23	₹1,24,800	1,600	₹78 - ₹82

Issue Size	IPO Doc
14.89Cr	RHP PDF

Apply as	Price band	Apply upto
Regular	₹78 - 82	₹2 Lakh
High Networth Individual	₹78 - 82	₹2 - 5 Lakh

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsIPOMutual FundsCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and Support
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemap
ⓒ 2016-2023 Groww. All rights reserved, Built with ♥in India

ABOUT GROWW

Groww is India’s growing financial services platform where users can find their investment solutions pertaining to mutual funds, stocks, US Stocks, ETFs, IPO, and F&Os, to invest their money without hassles.

Groww objectively evaluates stocks and mutual funds and does not advise or recommend any stocks, mutual funds or portfolios. Investors shall invest at their own discretion, will and consent. Groww, at any time, does not guarantee fixed returns on the capital invested.

Groww helps investors -

· By providing 100% paperless online free Demat and trading account opening

· By providing an objective evaluation of products available on the platform

· By being transparent about fees and charges involved while investing in a product

· By offering decision-making assistance by providing technical analysis with advanced charts, well-designed line & candlestick charts that indicate share price movements, and market indices, along with more details about all registered and listed companies

SECURE TRANSACTIONS ON GROWW

All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with Member code 11724) as transaction platform.

TRADE AND INVEST SECURELY WITH GROWW

Stocks, Mutual fund investments, F&Os, etc., are very popular with individual investors because of their numerous benefits. On Groww, an investor can -

- Invest in Nifty 50 (NSE) & Sensex (BSE) listed stocks

- Diversify across multiple stocks and other instruments

- Start SIP with any amount (as low as Rs. 500)

- Switch regular funds to direct funds

- Start automated monthly investments (SIP), and benefit from many more features

All type of mutual funds are available on Groww.

INVESTING IN MUTUAL FUND PORTFOLIOS

Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you.

ATTENTION INVESTORS

1. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

3. KYC is a one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

4. If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.

· Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

· Awareness regarding guidelines on Margin collection

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Issued in the interest of Investors

DISCLAIMER

NextBillion Technology Private Limited (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, Depository Participant of CDSL Depository with SEBI Registration no: IN-DP-417-2019 and Mutual Fund distributor with AMFI Registration No: ARN-111686. Registered office and Correspondence office - No.11, 2nd floor, 80 FT Road, 4th Block, S.T Bed, Koramangala, Bengaluru – 560034. For any grievances related to Stock Broking/DP, please write to [email protected] , please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

NextBillion Technology Private Limited makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Unless otherwise specified, all returns, expense ratio, NAV, etc are historical and for illustrative purposes only. Future will vary greatly and depends on personal and market circumstances. The information provided by our blog is educational only and is not investment or tax advice.

Mutual fund investments are subject to market risks. Please read all scheme related documents carefully before investing. Past performance of the schemes is neither an indicator nor a guarantee of future performance.

Terms and conditions of the website/app are applicable. Privacy policy of the website is applicable.